James Scott Whitehurst Net Worth

What's James Whitehurst's mailing address?

James's mailing address filed with the SEC is 8201 EAST RIVERSIDE DRIVE, BUILDING 4, SUITE 100, AUSTIN, TX, 78744.

Insiders trading at XBiotech Inc

Over the last 9 years, insiders at XBiotech Inc have traded over $50,443,920 worth of XBiotech Inc stock and bought 1,428,502 units worth $11,921,113 . The most active insiders traders include Street Financial S.A. Bay, Fondation Rennes oraz W Thorpe Mckenzie. On average, XBiotech Inc executives and independent directors trade stock every 48 days with the average trade being worth of $1,053,782. The most recent stock trade was executed by W Thorpe Mckenzie on 16 December 2021, trading 250,000 units of XBIT stock currently worth $2,500,000.

What does XBiotech Inc do?

xbiotech is developing a first-in-class monoclonal antibody (mabp1) to inhibit chronic inflammation. chronic (sterile) inflammatory responses are involved in the progression of many serious and common diseases. mabp1 is being investigated in many important areas of medicine, including: cancer, leukemia (phase 1); type 2 diabetes (phase2); psoriasis (phase 2); and vascular disease (phase 2). mabp1 is a true human™ antibody cloned from a natural human immune response and—unlike currently marketed antibodies—it has not undergone any modification to alter its function. it has exhibited the best potential tolerability and safety during the clinical trials. xbiotech has established a current good manufacturing practices (cgmp) program to commercialize its lead product candidate. the company has purchased land and designed a commercial-scale plant with 25,000l total bioreactor capacity. construction of the facility is planned to commence in 4th quarter 2011..

XBiotech Inc executives and stock owners

XBiotech Inc executives and other stock owners filed with the SEC include:

• John Simard,
  Chairman of the Board, President, Chief Executive Officer, Founder
• John Simard,
  Founder, Pres, CEO & Chairman
• Sushma Shivaswamy,
  Chief Scientific Officer
• Queena Han,
  Vice President - Finance and Human Resources, Secretary
• Dr. Sushma Shivaswamy,
  Chief Scientific Officer
• Queena Han CPA, B.A., CPA, C.G.A.,
  VP of Fin. & HR and Sec.
• W. Thorpe McKenzie,
  Independent Director
• Donald MacAdam,
  Independent Director
• Peter Libby,
  Independent Director
• Jan-Paul Waldin,
  Lead Independent Director
• Lisa Simard,
  Director of Corp. Strategy - XBiotech USA, Inc.
• Benjamín Guzmán,
  Sr. VP of Corp. Strategy & Fin.
• Daniel Vasella,
  Director
• Trey Benson,
  VP of Commercial Development
• Kelly Thornburg,
  SVP of Operations
• Fabrizio Bonanni,
  Director
• Dawn Mc Collough,
  VP Clinical Operations
• Michael Stecher,
  Medical Director
• Kalidip Choudhury,
  VP of Business Development
• James Scott Whitehurst,
  Chief Financial Officer
• Thomas Gut,
  10% owner
• Benjamin Guzman,
  Sr.VP Corp. Strategy & Finance
• Fondation Rennes,
  10% owner
• Street Financial S.A. Bay,
  10% owner